Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2023-08-01
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Immunological Effects of Exercise in Cancer Patients
NCT05656651
Cancer, Physical Activity and Quality of Life- a Longterm Follow up
NCT04083300
Physical Training and Cancer-a Multicenter Clinical Trial
NCT02473003
Effects of Moderate and High-intensity Exercise During Chemotherapy on Muscle Cells in Women With Breast Cancer
NCT05218876
Effectiveness of a Cancer Exercise Program
NCT06039488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital home-based resistance exercise
Participants in the digital group will need an e-mail and access to a pc and/or ipad at home. They will get access to a closed group on a digital platform, for participants in the project only. They will be asked to perform two pre-recorded resistance exercise sessions each week, for 12 weeks. Each session last for 40 minutes, and include 10 minutes of warm-up (ldynamic mobility and low impact), 25 minutes of resistance exercises (8-15 repetitions x 2-4 sets), and 5 minutes of cool-down and stretching. A total of 24 exercises will be performed over the period of 12 weeks.
Digital follow-up
See the arm/group description.
Resistance exercise
See the arm/group description.
On-site resistance exercise
Participants in the on-site group will be asked to participate in resistance exercise on-site with instructor, two times a week for 12 weeks. They will follow the exact same exercise program as the digital group. Participants living around the Gjøvik area will have their exercise sessions at The Inland hospital Gjøvik (with physiotherapist and instructor supervising/mentoring the students), and for participants living around Lillehammer the exercise will be held at a medical clinic (with physiotherapist and instructor supervising/mentoring the students). A total of 24 exercises will be performed over the period of 12 weeks.
On-site follow-up
See the arm/group description.
Resistance exercise
See the arm/group description.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital follow-up
See the arm/group description.
On-site follow-up
See the arm/group description.
Resistance exercise
See the arm/group description.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously diagnosed with any form of cancer and completed systemic chemotherapy, immunotherapy or targeted therapies or local radiotherapy
* Have completed active cancer treatment not more than 12 months earlier or at present undergoing oral home-based treatment for stabilization or other treatments of disease or to prevent relapse
* Life expectancy of more than 12 months
* Digital opportunities at home: e.g axcess to pc, and/or ipad, email adress to log on the platform
* Able to understand Norwegian language
Exclusion Criteria
* Conditions caused by the cancer which prohibits exercise like previous major surgery, fractures, pain
* Still undergoing active cancer treatment that is expected to confer a high risk of bone marrow suppresion that would lead to infections, bleeding and/or severly reduced physical capacity
* Life expectancy of less than 12 months
* Reduced mental capacity and not able to give informed consent and follow the program
* Travelling distance more than 20 km from home or workplace to the two exercise locations (Gjøvik and/or Lillehammer) for patients who are candidates for randomization
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sykehuset Innlandet HF
OTHER
Inland Norway University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stian Ellefsen
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inland Norway University of Applied Sciences
Lillehammer, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anne Mette Rustaden, PhD
Role: primary
Stian Ellefsen, Professor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TR033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.